STOCKWATCH
·
Pharmaceuticals
New Launch28 Nov 2025, 05:31 pm

Neuland Laboratories to Invest Rs. 189 Crs. in New State-of-the-art R&D Center

AI Summary

Neuland Laboratories Ltd. has approved a capital expenditure of Rs. 189 Crs. for setting up a new Research & Development (R&D) Center at the Company’s leased premises at Genome Valley, Plot No. 15B, Phase-l, MN Park, Shamirpet, Turkapally, Hyderabad, Telangana. The new R&D center, which will be built in a built-up area of about 1.35 lakh sq. ft., will replace the existing R&D center that is approximately 0.45 lakh sq.ft. The investment will be financed through borrowings and internal accruals.

Key Highlights

  • Neuland Laboratories to invest Rs. 189 Crs. in new R&D center
  • New R&D center to be built in a built-up area of about 1.35 lakh sq. ft.
  • Existing R&D center (approx. 0.45 lakh sq.ft.) to be relocated
  • Investment to be financed through borrowings and internal accruals
  • New R&D center to be set up at Genome Valley, Hyderabad, Telangana
NEULANDLAB
Pharmaceuticals
NEULAND LABORATORIES LTD.

Price Impact